The top pharmaceutical companies by R&D expenditure
Pharmaceutical Technology
MAY 2, 2024
From Merck & Co to Sanofi, Pharmaceutical Technology lists the leading pharmaceutical companies spending the most on R&D in 2023.
Pharmaceutical Companies Related Topics 
Biologics contract manufacturing: A comprehensive guide for pharmaceutical companies
pharmaphorum
JULY 29, 2024
This comprehensive guide provides pharmaceutical companies with valuable insights into biologics contract manufacturing, including the role of CDMOs and key considerations for successful partnerships.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Patients Often Lose in the Battle Between Pharmaceutical Companies and PBMs
Drug Topics
JULY 18, 2023
Over the last 5 years, both PBMs and drug manufacturers have implemented restrictions that raise patients’ cost burden for specialty medications.
STAT+: As pharmaceutical companies bemoan Medicare’s drug negotiations, hospitals and doctors stay mum
STAT
AUGUST 31, 2023
The pharmaceutical industry has been up in arms over Medicare’s first list of 10 prescription drugs that will be subject to negotiations. But other major parts of the health care industry — hospitals, doctors, and other providers — have refrained from either lending support or criticizing the government’s process.
FDA Approves Aprocitentan For Treatment of Uncontrolled High Blood Pressure
Drug Topics
MARCH 20, 2024
Aprocitentan (TRYVIO) from pharmaceutical company Idorsia demonstrated statistically significant and clinically meaningful reductions in blood pressure in combination with other antihypertensive therapies.
Artificial Intelligence is Changing the Face of Pharmacovigilance
Pharmacy Times
OCTOBER 17, 2022
Pharmaceutical companies are looking into AI as the new method to not only reduce research and development costs, but also prevent costly errors.
AstraZeneca Caps Out-of-Pocket Inhaler Costs at $35 Per Month
Drug Topics
MARCH 18, 2024
AstraZeneca is the second pharmaceutical company to cap out-of-pocket costs for eligible patients.
Opinion: Pharma’s ethically questionable sites essentially sell drugs directly to consumers
STAT
NOVEMBER 6, 2024
Some of the largest pharmaceutical companies in the U.S. This unprecedented move launches a new dystopic era: pharmaceutical companies as health care provider, no pesky physician middlemen needed. Want to self-prescribe a prescription drug? No problem!
STAT+: Hospital claims it was ‘drastically’ overcharged by pharma in a federal drug discount program
STAT
FEBRUARY 15, 2024
For several years , some of the world’s largest pharmaceutical companies that participate in a U.S. drug discount program overcharged the federal government and numerous hospitals by hundreds of millions of dollars, according to claims made in a recently unsealed lawsuit. and their number has grown over the years.
Hospitals 
134
134 
Is the flu shot market a slam dunk for mRNA vaccines? Experts aren’t so sure
STAT
DECEMBER 5, 2023
And pharmaceutical companies that learned of the vaccine-making power of the messenger RNA platform during the Covid-19 pandemic need new markets for their technology. Here are two things that are true. The world needs more effective flu vaccines. Read the rest…
Vaccines 145
145 
Opinion: The Pandemic Treaty will succeed only with investment to build strong health systems
STAT
MAY 31, 2024
The vested interests of pharmaceutical companies, lobbying groups, and conservative British broadcaster Nigel Farage bleating about “defending sovereignty” are threatening to derail the treaty process entirely. The treaty has been beset by delay and misinformation.
Novavax: Creating tomorrow’s vaccines today
pharmaphorum
JANUARY 10, 2024
Novavax is a leading pharmaceutical company dedicated to creating protein-based vaccines for diseases like COVID-19 and malaria. Learn more about their innovative vaccine development process and their commitment to creating a healthier future.
Vaccines 124
124 
Why is pharma going gaga for radiopharmaceuticals?
pharmaphorum
FEBRUARY 27, 2024
Pharmaceutical companies are increasingly focusing on radiopharmaceuticals due to their potential in oncology and therapeutic applications. Learn more about why the industry is excited about radioisotopes in this article.
Top U.S. addiction researcher calls GLP-1 data for addiction ‘very, very exciting’
STAT
MARCH 21, 2024
But even as she expressed enthusiasm for the new drugs’ potential, Volkow criticized pharmaceutical companies for neglecting a moral imperative to develop new addiction treatments — but acknowledged that the health system more broadly doesn’t incentivize drug companies to treat the U.S.
Pain is reduced by almost half with cannabis-based medicines – report finds
Outsourcing Pharma
MARCH 11, 2024
On March 7, Celadon Pharmaceuticals plc, a leading UK-based pharmaceutical company specializing in cannabis-based medicines, unveiled promising findings from an early economic analysis of its chronic pain clinical trial, dubbed CANPAIN.
AstraZeneca withdraws Covid-19 vaccine worldwide, citing surplus of newer vaccines
The Guardian - Pharmaceutical Industry
MAY 7, 2024
Pharmaceutical company says newer shots led to decline in demand for AstraZeneca vaccine, which is no longer being manufactured or supplied AstraZeneca has begun the worldwide withdrawal of its Covid-19 vaccine due to a “surplus of available updated vaccines” that target new variants of the virus.
Vaccines 111
111 
JPM24, Day 3: Alkermes enters new phase after busy year
Fierce Pharma
JANUARY 3, 2024
Morgan Healthcare Conference, attendees will get a chance to hear from AbbVie, Amarin and several other pharmaceutical companies. Morgan Healthcare Conference moves into its third day, we're covering the latest developments here. | On Wednesday at the the J.P.
Listen: Biotech layoffs, founder-focused VC, & a big pharma exit
STAT
JULY 11, 2024
Why are pharmaceutical companies cutting more staff than cash-strapped biotechs? And who will Pfizer scout out as its next science chief? STAT’s West Coast biotech reporter Jonathan Wosen joins “The Readout LOUD” to discuss what’s driving workforce cuts. Read the rest…
Sunshine transparency reporting for emerging pharma: Simplify, streamline, and secure
pharmaphorum
APRIL 10, 2024
Discover how Sunshine transparency reporting can be simplified, streamlined, and secured for emerging pharmaceutical companies with a focus on Healthcare Professionals (HCP) and Healthcare Organisations (HCO).
What can pharma companies do to quicken the pace of digital disruption?
pharmaphorum
JUNE 10, 2024
Discover how pharmaceutical companies can leverage digital technologies to accelerate innovation and disrupt the industry. Learn about regulatory considerations and engagement with healthcare professionals (HCPs) for successful digital transformation.
Watch: How drug patents pave the way to profit
STAT
AUGUST 8, 2024
Discovering a new drug is a big win for a pharmaceutical company, but selling it for lots of money with no competition? This is Part 3 of “Behind the Counter,” an in-depth video series demystifying the complex world of patents and drug pricing. The cherry on top. Read the rest…
What pharma stands to gain from technological innovation
pharmaphorum
APRIL 22, 2024
Pharmaceutical companies stand to gain significant benefits from technological innovation in the form of improved data analytics, streamlined healthcare processes, and enhanced patient outcomes. Explore the potential advantages for the pharma industry.
Johnson & Johnson accuses former employee of taking thousands of files to new role at Pfizer
Fierce Pharma
MARCH 20, 2024
As two of the world’s largest pharmaceutical companies, Johnson & Johnson and Pfizer have long been rivals in various therapeutic areas. | The company is accusing former employee Andrew Brackbill of downloading thousands of confidential strategy-related files before leaving for rival Pfizer.
STAT+: Pfizer plans to depart BIO
STAT
DECEMBER 5, 2023
The departure is a blow to BIO, which represents members ranging from small biotech startups to massive pharmaceutical companies. WASHINGTON — Pfizer has decided to leave the Biotechnology Innovation Organization, according to two sources familiar with the decision.
The race for obesity drug assets heats up
pharmaphorum
JANUARY 3, 2024
The race for obesity drug assets is becoming more intense as pharmaceutical companies strive to develop effective treatments for weight loss. This article explores the efficacy, potential sales, and market trends in the field of obesity drugs.
Long-overlooked scientist shares Lasker Award with other GLP-1 researchers
STAT
SEPTEMBER 19, 2024
Read the rest…
STAT+: FDA approves a gene therapy for the inherited bleeding disorder hemophilia B
STAT
NOVEMBER 22, 2022
The one-time treatment, called Hemgenix, was developed by the Dutch biotech company UniQure and will be marketed by CSL Behring, an Australian pharmaceutical company. The Food and Drug Administration on Tuesday approved the first gene therapy to treat people with hemophilia B, an inherited bleeding disorder.
Weight-loss drug firm accused of prioritising profits after halting insulin pen production
The Guardian - Pharmaceutical Industry
OCTOBER 16, 2024
Novo Nordisk’s decision will force people in developing countries to use outdated glass vials and syringes, warn campaigners The pharmaceutical company behind injectable weight-loss drugs has been accused of prioritising profits over the health of people in developing countries by halting production of its insulin pens.
STAT+: Eli Lilly reports tirzepatide MASH success during Q4 earnings
STAT
FEBRUARY 6, 2024
The blockbuster weight loss and diabetes drug sold by Eli Lilly also appears to improve fatty liver disease, according to early clinical trial data the pharmaceutical company released Tuesday.
To fight rare diseases, win the data battle first
pharmaphorum
DECEMBER 18, 2023
This article explores how pharmaceutical companies are leveraging AI and focusing on orphan drugs to tackle rare diseases. To effectively combat rare diseases, it is essential to prioritise the collection and analysis of data.
Industry can support clinicians with prescribing decisions
pharmaphorum
FEBRUARY 16, 2024
Find out more about how pharmaceutical companies can assist healthcare professionals in providing optimal patient care. The ABPI has released a new guide on how the industry can support clinicians with prescribing decisions.
How biometrics applications are contributing to clinical trial diversity
pharmaphorum
JULY 31, 2024
Ensuring equitable access to medications remains a fundamental commitment for many pharmaceutical companies to their customers, patients, and stakeholders. However, there has been a discernible shift recently in the timing of access discussions.
FDA Approves First Nonprescription Daily Birth Control Pill
Pharmacy Times
JULY 13, 2023
The approval of norgestrel tablets (Opill) could open the door to other prescription-to-OTC contraceptive switches, although that remains to be seen as other pharmaceutical companies weigh their options.
Cost of developing new drugs may be far lower than industry claims, trial reveals
The Guardian - Pharmaceutical Industry
APRIL 25, 2024
Exclusive: MSF calls for transparency after its bill for a trial of TB treatment came to a fraction of the billions claimed by pharmaceutical companies Doctors have for the first time released details of their spending on a major clinical trial, demonstrating that the true cost of developing a medicine may be far less than the billions of dollars claimed (..)
STAT+: Patent thickets and terminal disclaimers: How pharma blocks biosimilars from the marketplace
STAT
DECEMBER 21, 2023
To ring the register, a pharmaceutical company may create a patent thicket , which involves filing dozens of patents that, in some cases, add little value to their medicines but extend precious monopolies. As a result, a drug company can quickly add a number of patents that can be used to protect its medicines from would-be rivals.
Opinion: Senate, FTC cracking down on pharma patent shenanigans
STAT
JULY 2, 2024
These medications don’t have to be so expensive, but all too often pharmaceutical companies use illegal tactics to block competition that could lower prices and encourage innovation. Americans are facing an affordability crisis at the hands of corporate titans. Read the rest…
FDA Approves New Combination Therapy for BRCA-Positive Metastatic Castration-Resistant Prostate Cancer
Pharmacy Times
AUGUST 14, 2023
Niraparib and abiraterone acetate (Akeega; Janssen Pharmaceutical Companies of Johnson & Johnson) is the first-and-only dual action tablet that combines a PARP inhibitor with abiraterone acetate administered with prednisone.
STAT+: Health care CEOs dialed back their pay in 2023. They still made $3.5 billion
STAT
SEPTEMBER 30, 2024
The heads of pharmaceutical companies and medical device firms continued to sit at the top as their patented products reaped the biggest windfalls. Those figures compared to an average of $13 million and median of $4.3 million in 2022. Continue to STAT+ to read the full story…
You’re trusted less than a waiter and more than a pilot, but why?
pharmaphorum
AUGUST 8, 2024
Discover why pharmaceutical companies are trusted less than a waiter, but more than a pilot, and explore the role of Patient Advocacy Groups (PAGs) in shaping trust in the pharmaceutical industry.
Pfizer CEO Albert Bourla maxed out campaign contributions to Dr. Oz ahead of midterm elections
STAT
MARCH 9, 2023
Oz is well-known for spreading medical misinformation , including touting astrology as a legitimate medical tool and the myth that apple juice contains unsafe levels of arsenic — a surprising political ally for Bourla, who runs one of the largest pharmaceutical companies in the world. Read the rest…
The legal battle over drug price negotiations is just getting started
Fierce Healthcare
SEPTEMBER 13, 2023
Pharmaceutical companies are waging war against federal agencies over one of the Inflation Reduction Act’s major provisions allowing Medicare to negotiate 10 drugs to reduce out-of-pocket costs for | Legal experts question whether the Inflation Reduction Act is within its rights to enforce its drug pricing negotiation provision.
South Africans take on big pharma for access to ‘miracle’ cystic fibrosis drug
The Guardian - Pharmaceutical Industry
MARCH 17, 2024
Cheri Nel cannot afford Vertex’s Trikafta medicine, so she is suing to end ‘patent abuse’ and allow a generic version Cheri Nel has a blunt message for the multibillion-dollar pharmaceutical company Vertex: “Any person that dies from today – that’s on you.”
A Win for Indiana Patients: “Share the Savings” Legislation Now Law
PhRMA
MAY 8, 2023
Negotiations between pharmaceutical companies, health insurers, PBMs and others result in significant rebates and discounts that totaled $236 billion in 2021. However, those savings aren’t always shared with patients, which means there are patients who end up paying more for their medicine than their insurer and PBM.
Opinion: The FDA should withdraw approval of more than 400 tainted medicines
STAT
AUGUST 12, 2024
Instead, it has allowed these drugs to continue to be prescribed and distributed for at least a year as the pharmaceutical companies retest them for equivalency to the original brand-name drugs.
FDA 143
143 
Let's personalize your content